Cryo-Cell Intl Inc CCEL

$3.99 -0.06 (-1.48%)

Valuation

Market cap
32,654,000
Revenue TTM
$31,570,000
Net income TTM
$-2,430,000
PE ratio
0.00
Forward PE
—
Profit margin
-7.70%
Debt to equity
-0.45

Trading

Volume
1,500
Avg volume
27,038
Day's range
$3.99 – $4.11
Shares out
8,063,000
Stochastic %K
37%
Beta
0.50
Analysts
Hold
Price target
$8.50

Price

Company profile

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing...

Show more

Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Industry
Medical Care Facilities
Sector
Healthcare
Phone
813 749 2100
Website
https://www.cryo-cell.com
Address
700 Brooker Creek Boulevard, Suite 1800, Oldsmar, United States

Latest news

No headlines yet.